Clinical Trial Update: IIT PH1 KDS-1001 in Patients With CML [Phase 1]

View source ↗

Summary

The IIT Phase 1 trial of KDS-1001 in chronic myeloid leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• KDS-1001 (KDS-1001)

Snippet

Sponsor: Duke University | Conditions: CML (Chronic Myelogenous Leukemia | Phase 1 | Status: WITHDRAWN